1.Therapeutic landscape for inherited ocular diseases: Current and emerging therapies.
Hwei Wuen CHAN ; Jaslyn OH ; Bart LEROY
Singapore medical journal 2023;64(1):17-26
Inherited ocular diseases comprise a heterogeneous group of rare and complex diseases, including inherited retinal diseases (IRDs) and inherited optic neuropathies. Recent success in adeno-associated virus-based gene therapy, voretigene neparvovec (Luxturna®) for RPE65-related IRDs, has heralded rapid evolution in gene therapy platform technologies and strategies, from gene augmentation to RNA editing, as well as gene agnostic approaches such as optogenetics. This review discusses the fundamentals underlying the mode of inheritance, natural history studies and clinical trial outcomes, as well as current and emerging therapies covering gene therapy strategies, cell-based therapies and bionic vision.
Humans
;
Eye Diseases/therapy*
2.GAO Wei-bin's clinical experience of electric eye acupuncture and stagnant-moving needling for ophthalmopathy.
Shao-Peng LIU ; Hong-Na YIN ; Ming-Yuan HAN ; Xiao-Bei SUN ; Xiao-Lin LV ; Xiang-Xin ZENG ; Jia-Nuo LI ; Zhong-Ren SUN
Chinese Acupuncture & Moxibustion 2022;42(8):915-918
Professor GAO Wei-bin's clinical experience of electric eye acupuncture and stagnant-moving needling for ophthalmopathy was introduced. The indications of electric eye acupuncture and stagnant-moving needling include external ophtalmoplegia and visual impairment. Professor GAO has proposed new acupoints at the ocular muscles attachment of eyeball, and put forward five experience points: Shangming point, Neiming point, Xiaming point, Waiming point and Tijian point. The points are selected according to different pathological changes of ocular muscles. In the treatment of ophthalmopathy, the tendons and vessels are often regulated at the same time. Neiming point, Shangming point, Xiaming point and Qiuhou point are the main points, with Fengchi (GB 20) and Gongxue (Extra) as the matching points. In addition, attention is paid to the application of stagnant-moving needling and electroacupuncture (continuous dense wave, frequency of 50 Hz).
Acupuncture
;
Acupuncture Points
;
Acupuncture Therapy
;
Electroacupuncture
;
Eye Diseases
;
Humans
3.Peperomia pellucida (L.) Kunth and eye diseases: A review on phytochemistry, pharmacology and toxicology.
Keat Lam HO ; Phaik Har YONG ; Chee Woon WANG ; Umah Rani KUPPUSAMY ; Chek Tung NGO ; Festo MASSAWE ; Zhi Xiang NG
Journal of Integrative Medicine 2022;20(4):292-304
Peperomia pellucida (L.) Kunth is a medicinal plant used to manage inflammatory illnesses such as conjunctivitis, and gastrointestinal and respiratory tract disorders in tropical and subtropical regions. However, little is known about its pharmacological mechanism of action against eye diseases. This review aims to critically discuss the phytochemistry, pharmacology and toxicology of P. pellucida as well as its roles in the treatment of cataract, glaucoma and diabetic retinopathy. Recent developments in the uses of P. pellucida for healthcare and nutraceutical products by the pharmaceutical industry are also covered in this review. For this review, a literature search was performed with PubMed, ScienceDirect, SciFinder Scholar and Scopus databases, using relevant keywords. Among the various phytochemicals identified from P. pellucida, β-caryophyllene, carotol, dillapiole, ellagic acid, pellucidin A, phytol and vitexin exhibit strong pharmacological activities within the mitogen-activated protein kinase and nuclear factor-κB signalling pathways in inflammatory eye diseases. The antihypertensive, anti-inflammatory, antioxidant, antihyperglycemic and anti-angiogenic activities displayed by P. pellucida extracts in many in vitro, in vivo and clinical studies suggest its potential role in the management of inflammatory eye diseases. P. pellucida extract was non-toxic against normal cell lines but displayed mild toxicity in animal models. The growing public interest in P. pellucida has inspired the nutraceutical and pharmaceutical industries to process the plant into health products. Although the potential pharmacological mechanisms against eye diseases have been summarized, further studies of the interactions among constituent phytochemicals from P. pellucida within various signalling pathways shall support the use of the plant as an alternative therapeutic source.
Animals
;
Ethnopharmacology
;
Eye Diseases/drug therapy*
;
Peperomia
;
Phytochemicals/therapeutic use*
;
Phytotherapy
;
Plant Extracts/therapeutic use*
;
Plants, Medicinal
4.Advantages of scalp acupuncture at cranial base zone for refractory ophthalmopathy.
Bin YOU ; Jiruo YANG ; Ying WANG
Chinese Acupuncture & Moxibustion 2018;38(10):1109-1111
The cranial base zone is located in the lower posterior part of harnpan, the area 0.5 up and down from the line from Yamen (GV 15) to Yifeng (TE 17). There are Tianzhu (BL 10) in the bladder meridian, Fengchi (GB 20) and Wangu (GB 12) in the gallbladder meridian, and Yiming (EX-HN 14). The four acupoints own the function of treating eye diseases. The auther find acupuncture at the cranial base zone can obviously improve the effect on refractory eye diseases. The manipulation mainly shows small amplitude lifting and thrusting with multiple filiform needles. The functions of exciting meridian , smoothing meridian and collateral, and making go into the sick part fast could occur with eye movement and orbital relaxation movement during manipulation. Thus, the effect is achieved. This paper explain the advantages of acupuncture at the cranial base zone for eye diseases in detail, with 1 case for example.
Acupuncture Points
;
Acupuncture Therapy
;
Eye Diseases
;
therapy
;
Humans
;
Scalp
;
Skull Base
5.Review and update for central serous chorioretinopathy.
Hanyang Medical Reviews 2017;37(1):10-17
Central serous chorioretinopathy (CSC) is an eye disease that causes serous retinal detachment in the posterior pole of the retina. The pathogenesis of CSC is not fully understood and various systemic factors have been reported to be associated with CSC. Recently, with the advent of advanced imaging techniques, novel imaging findings for CSC have been reported and the understanding of CSC has increased further. Moreover, in addition to conventional treatment for CSC, new treatment modalities such as photodynamic therapy, anti-vascular endothelial growth factor or subthreshold laser therapy, have emerged. In this article, an overall review and update of CSC, particularly focusing on new imaging findings and treatments, will be discussed.
Central Serous Chorioretinopathy*
;
Endothelial Growth Factors
;
Eye Diseases
;
Laser Therapy
;
Photochemotherapy
;
Retina
;
Retinal Detachment
;
Tomography, Optical Coherence
6.Retrospective Analysis of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in 88 Chinese Patients.
Chinese Medical Journal 2017;130(9):1062-1068
BACKGROUNDStevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening diseases with high mortality rates. This study was designed to analyze the pathogenic factors, clinical manifestations, complications, treatment, and prognosis of SJS/TEN and to explore the differences between surviving and deceased patients.
METHODSSJS/TEN patients admitted to Beijing Friendship Hospital from January 2006 to December 2015 were included in the study. Patients' data were retrospectively analyzed. Comparative studies were performed on the survival group and the deceased group, and Fisher's exact probability test was used for statistical analysis.
RESULTSAmong the 88 patients included, 40 (45.5%) were male with a mean age of 45 ± 18 years. Forty-eight (54.5%) had SJS, 34 (38.6%) had SJS/TEN, and 6 (6.8%) had TEN. Fifty-three (60.2%) cases were caused by medications, mainly antibiotics (n = 24) followed by traditional Chinese medicines (n = 7). Forty-two cases (47.7%) developed visceral damage. Eighty-two patients improved or recovered and were discharged from hospital, and six patients died. Comparative studies on the survival group and the deceased group showed that the presence of malignant tumor ( χ2 = 27.969,P < 0.001), connective tissue diseases ( χ2 = 9.187, P= 0.002), previous abnormal liver/kidney functions ( χ2 = 6.006, P= 0.014), heart rate >100 times/min ( χ2 = 6.347, P= 0.012), detached skin area >20% ( χ2 = 5.594, P= 0.018), concurrent mucosal involvement at the mouth, eyes, and external genitals ( χ2 = 4.945, P= 0.026), subsequent accompanying liver/kidney damage ( χ2 = 11.839, P= 0.001, and χ2 = 36.302,P < 0.001, respectively), and SCORTEN score >2 ( χ2 = 37.148,P < 0.001) increased the risk of death.
CONCLUSIONSSJS/TEN is mainly caused by medications, and nearly half of patients develop visceral damage. Multiple factors increase the mortality risk.
Adult ; Anti-Bacterial Agents ; therapeutic use ; Connective Tissue Diseases ; metabolism ; pathology ; Eye ; pathology ; Female ; Genitalia ; pathology ; Humans ; Kidney ; metabolism ; pathology ; Liver ; metabolism ; pathology ; Male ; Middle Aged ; Mouth ; pathology ; Retrospective Studies ; Skin ; metabolism ; pathology ; Stevens-Johnson Syndrome ; drug therapy ; metabolism ; pathology
7.Hereditary vitreous degeneration muddy: report of ten cases.
Zhixin SHEN ; Enfang GAO ; Wenqing WENG ; Weiling LUO
Journal of Zhejiang University. Medical sciences 2016;45(6):636-640
Hereditary vitreous degeneration muddy is rare in clinic. Here we report ten cases (thirteen eyes) of hereditary vitreous degeneration muddy from two families. All patients presented with vitreous opacity, and the textures appeared tough and tensile. Two cases had concurrent detachment of rhegmatogenous retina. HE staining showed red changeableness, and methyl violet staining appeared purple. All patients received vitrectomy with traditional Chinese medicine treatment, and got satisfactory efficacy.
Eye Diseases, Hereditary
;
diagnosis
;
pathology
;
surgery
;
therapy
;
Female
;
Humans
;
Male
;
Medicine, Chinese Traditional
;
Retinal Detachment
;
diagnosis
;
surgery
;
Vitrectomy
;
Vitreous Body
;
pathology
;
surgery
8.Effects of Systemic Administration of Dexmedetomidine on Intraocular Pressure and Ocular Perfusion Pressure during Laparoscopic Surgery in a Steep Trendelenburg Position: Prospective, Randomized, Double-Blinded Study.
Jin JOO ; Hyunjung KOH ; Kusang LEE ; Jaemin LEE
Journal of Korean Medical Science 2016;31(6):989-996
Increased intraocular pressure (IOP) during surgery is a risk factor for postoperative ophthalmological complications. We assessed the efficacy of systemically infused dexmedetomidine in preventing the increase in IOP caused by a steep Trendelenburg position, and evaluated the influence of underlying hypertension on IOP during surgery. Sixty patients undergoing laparoscopic surgery in a steep Trendelenburg position were included. Patients in the dexmedetomidine group received a 1.0 µg/kg IV loading dose of dexmedetomidine before anesthesia, followed by an infusion of 0.5 µg/kg/hr throughout the operation. Patients in the saline group were infused with the same volume of normal saline. IOP and ocular perfusion pressure (OPP) were measured 16 times pre- and intraoperatively. In the saline group, IOP increased in the steep Trendelenburg position, and was 11.3 mmHg higher at the end of the time at the position compared with the baseline value (before anesthetic induction). This increase in IOP was attenuated in the dexmedetomidine group, for which IOP was only 4.2 mmHg higher (P < 0.001 vs. the saline group). The steep Trendelenburg position was associated with a decrease in OPP; the degree of decrease was comparable for both groups. In intragroup comparisons between patients with underlying hypertension and normotensive patients, the values of IOP at every time point were comparable. Dexmedetomidine infusion attenuated the increase in IOP during laparoscopic surgery in a steep Trendelenburg position, without further decreasing the OPP. Systemic hypertension did not seem to be associated with any additional increase in IOP during surgery. (Registration at the Clinical Research Information Service of Korea National Institute of Health ID: KCT0001482)
Aged
;
Dexmedetomidine/administration & dosage/*pharmacology
;
Double-Blind Method
;
Eye Diseases/surgery
;
Female
;
Head-Down Tilt
;
Humans
;
Hypnotics and Sedatives/administration & dosage/pharmacology
;
Intraocular Pressure/*drug effects
;
Intraoperative Complications/drug therapy/prevention & control
;
Laparoscopy
;
Male
;
Middle Aged
;
Prospective Studies
;
Risk Factors
;
Tonometry, Ocular
;
Treatment Outcome
10.Successful Treatment of Infectious Scleritis by Pseudomonas aeruginosa with Autologous Perichondrium Graft of Conchal Cartilage.
Woong Sun YOO ; Che Ron KIM ; Byung Jae KIM ; Seong Ki AHN ; Seong Wook SEO ; Ji Myong YOO ; Seong Jae KIM
Yonsei Medical Journal 2015;56(6):1738-1741
Infectious scleritis by Pseudomonas aeruginosa is a well-known vision-threatening disease. In particular, scleral trauma following pterygium surgery may increase the risk of sclera inflammation. Surgical debridement and repair is necessary in patients who do not respond to medical treatments, such as topical and intravenous antibiotics. We reports herein the effectiveness of an autologous perichondrium conchal cartilage graft for infectious scleritis caused by Pseudomonas aeruginosa. This procedure was performed on four eyes of four patients with infectious scleritis who had previously undergone pterygium surgery at Gyeongsang National University Hospital (GNUH), Jinju, Korea from December 2011 to May 2012. Pseudomonas aeruginosa was identified in cultures of necrotic scleral lesion before surgery. The conchal cartilage perichondrium graft was transplanted, and a conjunctival flap was created on the scleral lesion. The autologous perichondrium conchal cartilage graft was successful and visual outcome was stable in all patients, with no reports of graft failure or infection recurrence. In conclusion, autologous perichondrium conchal cartilage graft may be effective in surgical management of Pseudomonal infectious scleritis when non-surgical medical treatment is ineffective. Further studies in larger, diverse populations are warranted to establish the effectiveness of the procedure.
Anti-Bacterial Agents/therapeutic use
;
Autografts
;
Cartilage/surgery
;
Communicable Diseases
;
Debridement
;
Eye Infections, Bacterial/etiology/*therapy
;
Female
;
Humans
;
Ophthalmologic Surgical Procedures
;
Postoperative Complications
;
Pseudomonas Infections/microbiology/*therapy
;
Pseudomonas aeruginosa/*isolation & purification
;
Pterygium/surgery
;
Republic of Korea
;
Sclera/*surgery/transplantation
;
Scleritis/microbiology/*therapy
;
Surgical Wound Infection/microbiology/*therapy
;
Transplantation, Autologous
;
Treatment Outcome

Result Analysis
Print
Save
E-mail